Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) announced on 13 November 2013 the next stage of their joint efforts toward regulatory harmonization and the launch of a joint regulatory agency, the Australia New Zealand Therapeutic Products Agency (ANZTPA)..

This new phase of joint work will cover the next two and a half years and targets 14 activities across the following six regulatory areas: medicines (prescription and non-prescription), medicines ingredients, safety, medical devices, and biological and blood products.

The Medsafe/TGA ANZTPA Implementation Steering Committee will oversee the multiple harmonization activities to link with the ongoing Australian Blueprint reforms program and the needed timing for ANZTPA Rules and Orders development.

ANZTPA Statement

Read all Breaking News from RegLink